Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-26-037361
Filing Date
2026-08-12
Accepted
2026-08-12 16:15:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 19032
2 GRAPHIC proxy_001.jpg GRAPHIC 548294
3 GRAPHIC proxy_002.jpg GRAPHIC 447002
  Complete submission text file 0001493152-26-037361.txt   1391255
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41245 | Film No.: 261267660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)